Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00125177 · ClinicalTrials.gov registry record · Phase 1
IRIS: Incontinence Research Intervention Study
A Phase 1 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 1
- Development phase
- 320
- Enrollment target
NCT00125177: Completed Phase 1 study, sponsored by University of Michigan.
NCT00125177 is a Phase 1 study that has completed, run by University of Michigan. The registered enrollment target is 320 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (433% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00125177, a Phase 1 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 320 participants
- Enrollment target
Study Summary
The IRIS project stands for Incontinence Research Intervention Study. The purpose of this research project is to develop an effective behavioral therapy for urinary incontinence and specifically to test Knack therapy, a self-help treatment. The Knack therapy involves learning the skill of performing a pelvic muscle contraction simultaneously with an event known to trigger leakage, in order to stop that leakage.
Interventions
- BEHAVIORAL Knack therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2003-01 |
| Est. Completion | 2008-04 |
| Phase | Phase 1 |
What the finished NCT00125177 record still lists
NCT00125177 is an interventional study that assigns participants to a tested intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (433% higher).
The record links to 0 conditions, and to 1 intervention - of which Knack therapy is the first listed.
NCT00125177 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00125177 about?
NCT00125177 is a clinical study titled "IRIS: Incontinence Research Intervention Study". The IRIS project stands for Incontinence Research Intervention Study. The purpose of this research project is to develop an effective behavioral therapy for urinary incontinence and specifically to test Knack therapy, a self-help treatment. The Knack therapy involves learning the skill of performing...
What is the current status of trial NCT00125177?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 320 participants. The study started on 2003-01. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00125177?
The interventions under investigation include: Knack therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00125177?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00125177's enrollment target sits among peer trials
320 112th of 2000 higher than 1,885 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia